January 13, 2023 An annus horribilis for medtech flotations Bausch & Lomb saves 2022's medtech IPO scene from washout as markets close for new entrants.
July 22, 2022 Venture financing holds steady for device makers Medtech VCs have plenty of cash, which is just as well because the IPO window is shut and locked.
